Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Neural Basis of Capability for Suicide

NCT03327129 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03327129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Neural Basis of Capability for Suicide
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Suspended
Start date
January 1, 2023
Completion date
September 30, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, psychiatric illness, suicidal ideation, suicide